Verastem, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Verastem, Inc. on November 12, 2019. The filing details a material definitive agreement involving a debt exchange transaction with accredited investors and qualified institutional buyers holding the Company's existing 5.00% Convertible Senior Notes due 2048.
Key Financial Metrics and Transaction Details
- Debt Exchange: Approximately $114.3 million aggregate principal amount of Existing Notes exchanged for approximately $62.9 million aggregate principal amount of new 5.00% Convertible Senior Second Lien Notes due 2048.
- Cash Consideration: Exchanging investors receive a cash payment equal to 10.0% of the principal amount of Existing Notes exchanged, plus accrued and unpaid interest.
- Conversion Terms: Initial conversion rate is 606.0606 shares per $1,000 principal amount (approx. $1.65 per share), representing a 52.8% premium to the November 11, 2019 stock price of $1.08.
- Equity Dilution: Based on the initial maximum conversion rate, approximately 58.2 million shares of common stock are initially issuable upon conversion.
- Liquidity and Covenants: The transaction requires an amendment to the existing senior secured credit facility with Hercules Capital, Inc., subject to liquidity thresholds and financial covenants.
Material Changes and Structural Impacts
The transaction results in a significant reduction of the principal amount of outstanding convertible debt (from $114.3 million to $62.9 million) in exchange for cash payments and new debt instruments. The new Notes are senior, secured obligations with a second lien on Company assets, subordinate to the existing senior secured credit facility. The filing does not provide comparative revenue, profit, or cash flow metrics for the period, as this is a transactional filing rather than a periodic financial report.
Outlook, Risks, and Contingencies
- Closing Date: Expected to close on November 14, 2019, subject to customary conditions.
- Redemption and Repurchase: The Company may redeem Notes on or after November 1, 2022. Holders have repurchase options on specific dates starting November 1, 2023.
- Make-Whole Provisions: Early conversion prior to November 1, 2020 (outside of mandatory conversion rights) triggers a cash interest make-whole payment for future scheduled interest through that date.
- Fundamental Change: Holders may require the Company to purchase Notes at 100% of principal plus accrued interest if a "Fundamental Change" occurs.
- Regulatory Status: The Notes and underlying shares are unregistered, relying on Section 4(a)(2) and Section 3(a)(9) exemptions of the Securities Act.
Investor Verification Checklist
- Verify the final closing of the transaction on or around November 14, 2019.
- Confirm the specific liquidity thresholds and financial covenants imposed in the Credit Facility Amendment with Hercules Capital, Inc.
- Monitor the Company's cash position to ensure it can meet the 10% cash payment obligation to exchanging investors.
- Review the full text of the Indenture (Exhibit 10.1) for detailed definitions of "Fundamental Change" and "Make-Whole Fundamental Change."
- Assess the potential dilution impact of the 58.2 million shares issuable upon conversion relative to the current share count.